Incyte Corp. Stock
Incyte Corp. Stock
The Incyte Corp. stock is trending slightly upwards today, with an increase of €0.39 (0.820%) compared to yesterday's price.
With 10 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 78 € shows a very positive potential of 62.16% compared to the current price of 48.1 € for Incyte Corp..
For the coming years our community has positive and negative things to say abot the Incyte Corp. stock. Criterium "EBIT growth" gathered the most positive votes but regarding "Customer and product portfolio" there were negative voices in the community.
Pros and Cons of Incyte Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Cons
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Incyte Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Incyte Corp. | 0.820% | -3.849% | -10.015% | -29.982% | -15.915% | -32.537% | -27.613% |
Exact Sciences | 1.920% | -8.132% | -4.464% | -5.469% | -20.050% | -50.506% | -34.936% |
Regeneron Pharmaceuticals Inc. | -0.510% | -1.120% | -6.562% | 15.386% | 4.100% | 105.699% | 165.070% |
Amgen Inc. | 0.340% | 1.742% | -3.106% | 12.422% | -3.626% | 18.244% | 55.511% |
Comments
Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $92.00 to $84.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $81.00 price target on the stock.
Show more
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Citigroup Inc. from $82.00 to $81.00. They now have a "buy" rating on the stock.
Show more
Ratings data for INCY provided by MarketBeat